9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-morpholinyl)pyridin-3-yl]purine

CAT:
804-HY-152704
Size:
Inquire
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-morpholinyl)pyridin-3-yl]purine - image 1

9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-morpholinyl)pyridin-3-yl]purine

  • UNSPSC Description:

    9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-[6-(4-morpholinyl)pyridin-3-yl]purine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
  • Target Antigen:

    Nucleoside Antimetabolite/Analog
  • Type:

    Oligonucleotides
  • Related Pathways:

    Cell Cycle/DNA Damage
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Others
  • Assay Protocol:

    https://www.medchemexpress.com/9-3-deoxy-3-fluoro-β-d-ribofuranosyl-6-6-4-morpholinyl-pyridin-3-yl-purine.html
  • Solubility:

    10 mM in DMSO
  • Smiles:

    O[C@@H]1[C@H](F)[C@@H](CO)O[C@H]1N2C(N=CN=C3C4=CN=C(N5CCOCC5)C=C4)=C3N=C2
  • Molecular Weight:

    416.41
  • References & Citations:

    [1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported
  • CAS Number:

    1612191-98-6